Showing results (211-220 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|October 11, 2021
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 studySarah C Rutherford, Jeremy S Abramson, Nancy L Bartlett, et al.
The Lancet. Haematology|April 28, 2022
Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort studyCurtis A Lachowiez, Patrick K Reville, Hagop Kantarjian, et al.
The Lancet. Haematology|April 28, 2022
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology AssociationJannik Stemler, Nick de Jonge, Nicole Skoetz, et al.
The Lancet. Haematology|July 17, 2022
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trendsJunjie Huang, Sze Chai Chan, Veeleah Lok, et al.
The Lancet. Haematology|June 19, 2019
Treatment value of second-generation BCR-ABL1 tyrosine kinase inhibitors compared with imatinib to achieve treatment-free remission in patients with chronic myeloid leukaemia: a modelling studyYa-Chen Tina Shih, Jorge E Cortes, Hagop M Kantarjian
The Lancet. Haematology|October 14, 2019
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trialDietrich Wilhelm Beelen, Rudolf Trenschel, Matthias Stelljes, et al.
The Lancet. Haematology|April 3, 2022
Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trialRajat Bannerji, Jon E Arnason, Ranjana H Advani, et al.
The Lancet. Haematology|March 28, 2022
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort studyHabib El-Khoury, David J Lee, Jean-Baptiste Alberge, et al.
The Lancet. Haematology|March 3, 2022
Transplantation for Fanconi anaemia: lessons learned from BrazilCarmem Bonfim, Samantha Nichele, Gisele Loth, et al.
The Lancet. Haematology|August 30, 2016
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE studyMarjolein P A Brekelmans, Walter Ageno, Ludo F Beenen, et al.
Pageof 73